BIOMARIN PHARMACEUTICAL INC Total Liabilities
BIOMARIN PHARMACEUTICAL INC (BMRN) had Total Liabilities of $5.40 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-06
- 2026-06-30: Liabilities $5.40B.
- 2026-03-31: Liabilities $2.38B.
- 2025-12-31: Liabilities $1.51B.
- 2025-09-30: Liabilities $1.56B.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $5.40B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $2.38B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $1.51B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.56B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $1.43B 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $1.35B 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $1.33B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.44B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $1.78B 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $1.80B 10-Q · filed 2024-04-26 | |
| 2023-12-31 | $1.89B 10-K · filed 2025-02-24 | |
| 2023-09-30 | $1.86B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.78B 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $1.77B 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $1.77B 10-K · filed 2024-02-26 | |
| 2022-09-30 | $1.70B 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $1.64B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.67B 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $1.74B 10-K · filed 2023-02-27 | $1.73B 10-K · filed 2022-02-25 |
| 2021-09-30 | $1.71B 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $1.66B 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $1.64B 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $1.74B 10-K · filed 2022-02-25 | |
| 2020-09-30 | $2.10B 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $2.07B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.48B 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $1.57B 10-K · filed 2021-02-26 | |
| 2019-09-30 | $1.48B 10-Q/A · filed 2019-11-04 | |
| 2019-06-30 | $1.43B 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $1.50B 10-Q · filed 2019-04-29 | |
| 2018-12-31 | $1.46B 10-K · filed 2020-02-27 | |
| 2018-09-30 | $1.78B 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $1.74B 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $1.79B 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $1.82B 10-K · filed 2019-02-28 | |
| 2017-09-30 | $1.77B 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $1.22B 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $1.17B 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $1.26B 10-K · filed 2018-02-26 | |
| 2016-09-30 | $1.20B 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $1.17B 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $1.38B 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $1.33B 10-K · filed 2017-02-27 | |
| 2015-09-30 | $1.33B 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $1.29B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $1.23B 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $947.49M 10-K · filed 2016-02-29 | $962.56M 10-K · filed 2015-03-02 |
| 2014-09-30 | $931.99M 10-Q · filed 2014-10-28 | |
| 2014-06-30 | $883.72M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $880.61M 10-Q · filed 2014-05-02 | |
| 2013-12-31 | $903.02M 10-K · filed 2015-03-02 | $908.18M 10-K · filed 2014-02-26 |
| 2013-09-30 | $344.04M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $343.26M 10-Q · filed 2013-07-29 | |
| 2013-03-31 | $348.14M 10-Q · filed 2013-04-29 | |
| 2012-12-31 | $552.58M 10-K · filed 2014-02-26 | $585.88M 10-K · filed 2013-02-26 |
| 2012-09-30 | $552.18M 10-Q · filed 2012-10-29 | |
| 2012-06-30 | $532.10M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $525.13M 10-Q · filed 2012-04-30 | |
| 2011-12-31 | $532.66M 10-K · filed 2013-02-26 | $530.63M 10-K · filed 2012-02-22 |
| 2011-09-30 | $520.54M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $548.09M 10-Q · filed 2011-08-01 | |
| 2011-03-31 | $543.31M 10-Q · filed 2011-04-29 | |
| 2010-12-31 | $545.37M 10-K · filed 2012-02-22 | |
| 2010-09-30 | $658.87M 10-Q · filed 2010-10-29 | |
| 2010-06-30 | $622.55M 10-Q · filed 2010-08-04 | |
| 2009-12-31 | $594.98M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |